<DOC>
	<DOCNO>NCT00397540</DOCNO>
	<brief_summary>The purpose study evaluate effect serum hepatitis B virus ( HBV ) DNA level intrahepatic recurrence locally treatable hepatocellular carcinoma ( HCCs ) relate HBV .</brief_summary>
	<brief_title>The Effect Viral Load Intrahepatic Recurrence Hepatitis B Virus ( HBV ) -Related Hepatocellular Carcinoma ( HCC )</brief_title>
	<detailed_description>Prospective cohort study Survival - Overall survival rate - Disease free survival rate Recurrence - Cumulative recurrence rate</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>ChildPugh Class A B Maximal tumor size le 5 cm No previous history treatment hepatocellular carcinoma Recurrent hepatocellular carcinoma locate 2 cm previous cancer site find 1 year 's gap Hepatocellular carcinoma portal vein Hepatocellular carcinoma hepatic vein</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>HBV DNA</keyword>
	<keyword>HCC</keyword>
	<keyword>recurrence</keyword>
	<keyword>PEIT</keyword>
	<keyword>RFTA</keyword>
</DOC>